Amorepacific아모레퍼시픽

Amorepacific's trailing profits have recovered from 2023 lows, but its share price is down 11.8% over the past month.

Amorepacific, a major Korean cosmetics group with brands such as Sulwhasoo, Hera, Laneige and COSRX, reported trailing twelve-month revenue of ₩4.49T and operating income of ₩388B to H1 2026. Revenue grew 9.5% in 2025, and the stock closed at ₩125,700 on 26 October 2026, well below its 52-week high of ₩169,000. The data does not include analyst ratings or forecasts for future earnings.

What stands out

• Trailing operating margin is 8.6%, up from 2.9% in 2023 and 7.9% in 2025, but 2024 net income of ₩593B was inflated relative to operating income, so year-to-year profit comparisons are uneven.
• Balance sheet looks conservative: liabilities are 25.8% of equity, cash is ₩523B against borrowings of ₩231B, and trailing free cash flow is ₩438B.
• Trailing ROE is 5.3%, which is modest, and the stock trades at 1.3 times book value and 25.7 times trailing earnings.
• The DCF model in the data gives a base value of ₩65,562 with a bear-to-bull range of ₩38,705 to ₩111,997, well below the current price; the data does not explain the model's assumptions in detail.
• Recent headlines are mostly product launches and brand expansion (Sulwhasoo entering Harrods, new Hera and Iope products), plus a chairman share gift to relatives reported on 20 October.

What to watch

• The advance notice of earnings results filed on 22 October signals upcoming results; the full figures are not in the data.
• Filings on 20 October report a change in the largest shareholder's holdings and insider share transactions, which may affect sentiment.
• Retail investors have been net sellers over the past 20 days (about -₩24.8B), while institutions were net buyers (about +₩29.9B); foreign ownership rose to 26.2% from 25.2% over 60 days.